Letter to the Editor

PCC
Knowledge of ECT for Catatonia
PCC
Knowledge of Catatonia: Reply to Espinoza and Kellner
JCP
Misleading Labeling of S-Methadone as a Novel N-Methyl-D-Aspartate Receptor Antagonist
JCP
Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides
JCP
Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al
JCP
Toward Consensus in Psychedelic-Assisted Therapy: The Critical Role of Psychotherapeutic Support
JCP
Suicide Risk among Patients with Bipolar Disorder: Sleep Disruption versus Benzodiazepine Use
PCC
Reversible Cerebral Vasoconstriction Syndrome and Marijuana
PCC
Onco-Psychopharmacology: Is Mirtazapine a Catholicon?
PCC
Community-Based Alternatives in Behavioral Crisis Transport
JCP
Erecting Barriers to Suicide by Removing Barriers to Science
PCC
Revisiting Ayahuasca: Vine of the Soul of the Amazon
PCC
Cannabis Withdrawal Psychosis
PCC
Cannabis Withdrawal Psychosis: Reply to Gorelick
PCC
Parenting Young Adults With ADHD
JCP
The Need for Clinical Guidance on Ketamine/Esketamine Use in Clinical Settings
JCP
Opioid Use Disorder in Sexually and Gender Diverse Populations: Can We Do Better?
PCC
JCP
Mental Health Assessment and Psychosocial Intervention in Maternal-Fetal Interventions
JCP
Clarification Regarding the Psychiatrist’s Role—Reply to Akerson et al
PCC
Is Bariatric Surgery an Antidepressant?
JCP
Detecting Misuse of Prescription Opioids
PCC
Harm Reduction in Adolescent Inhalant Use
PCC
Empathy in AI: Insights from Psychodermatology